- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07693582
Smartphone-Based Digital Literacy Training for Older Adults
Smartphone-based Digital Literacy Training for Older Adults in a Lifelong-learning Setting: a Nonrandomised Wait-list-controlled Study With 3-month Follow-up
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
The training programme consisted of 12 sessions delivered over 6 weeks (two sessions per week, each lasting 90 to 105 minutes). Content was mapped to the DigComp 2.2 digital competence framework and covered practical smartphone skills for everyday life. Sessions used participants' own Android smartphones together with a projector for demonstration, a class messaging group for support, and between-session practice tasks. The intervention arm comprised the advanced-level cohort of the Akdeniz University 60+ Refresher (Tazelenme) University, and the wait-list control arm comprised the second-year cohort of the same programme.
Two instruments were used. Digital literacy was assessed with the Digital Literacy Scale (score range 12 to 60), the primary outcome. Smartphone self-efficacy was assessed with the Smartphone Self-Efficacy Scale (score range 20 to 100), a secondary outcome. Both were administered at baseline (T1), immediately after the intervention (T2), and at three-month follow-up (T3). Programme satisfaction was assessed with a short questionnaire after the intervention.
The primary analysis used a baseline-adjusted linear mixed model on the full analysis set, including a group-by-baseline interaction and adjustment for age, sex, education, and marital status. Robustness was examined through several pre-specified sensitivity analyses, including per-protocol analysis, difference-in-differences, propensity-score overlap weighting, multiple imputation, and a conservative worst-case (missing-not-at-random) analysis.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Antalya, Turkije (Türkiye), 07070
- Akdeniz University 60+ Tazelenme University
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Aged 60 years or older
- Enrolled in the Akdeniz University 60+ Refresher (Tazelenme) University programme
- Owns and regularly uses an smartphone
- Able to attend the scheduled training sessions
- Provides written informed consent
Exclusion Criteria:
- Severe cognitive, visual, or hearing impairment that would prevent participation in the training
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ander
- Toewijzing: Niet-gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Smartphone-based digital literacy training
Advanced-level cohort receiving a structured smartphone training programme: 12 sessions over 6 weeks (two sessions per week, 90 to 105 minutes each), mapped to the DigComp 2.2 framework, using participants' own Android smartphones.
|
Instructor-led smartphone training delivered in 12 sessions over 6 weeks (twice weekly, 90 to 105 minutes), mapped to the DigComp 2.2 framework, using participants' own Android smartphones, a projector for demonstration, a class messaging group, and between-session practice tasks.
|
|
Geen tussenkomst: Wait-list control
Second-year cohort continuing usual programme activities with the training deferred; served as the comparison group.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Digital Literacy Scale (DLS) score
Tijdsspanne: Baseline (T1), immediately post-intervention (approximately week 6, T2), and 3-month follow-up (T3)
|
Digital literacy assessed with the Digital Literacy Scale.
Scores range from a minimum of 12 to a maximum of 60.
Higher scores indicate greater digital literacy (a better outcome).
|
Baseline (T1), immediately post-intervention (approximately week 6, T2), and 3-month follow-up (T3)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Smartphone Self-Efficacy Scale (SSES) score
Tijdsspanne: Baseline (T1), immediately post-intervention (approximately week 6, T2), and 3-month follow-up (T3)
|
Smartphone self-efficacy assessed with the Smartphone Self-Efficacy Scale.
Scores range from a minimum of 20 to a maximum of 100.
Higher scores indicate greater smartphone self-efficacy (a better outcome).
|
Baseline (T1), immediately post-intervention (approximately week 6, T2), and 3-month follow-up (T3)
|
|
Programme satisfaction
Tijdsspanne: Immediately post-intervention (approximately week 6, T2)
|
Participant satisfaction with the training programme, assessed with a 10-item satisfaction questionnaire.
Scores range from a minimum of 10 to a maximum of 50.
Higher scores indicate greater satisfaction (a better outcome).
|
Immediately post-intervention (approximately week 6, T2)
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie directeur: Gülüşan Özgün Başıbüyük, Akdeniz University
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- TBAEK-181
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Beschrijving IPD-plan
IPD-tijdsbestek voor delen
IPD-toegangscriteria voor delen
IPD delen Ondersteunend informatietype
- ANALYTIC_CODE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .